Kalium phosphoricum comp. in patients with neurasthenia: a randomized, double-blind, placebo-controlled clinical trial
J Hellhammer, L Spitznagel-Schminke… - … Medical Research and …, 2024 - Taylor & Francis
Abstract Objective This Phase IV placebo-controlled clinical trial was designed to
demonstrate the efficacy and safety of the product Neurodoron (Kalium phosporicum comp …
demonstrate the efficacy and safety of the product Neurodoron (Kalium phosporicum comp …
Neurodoron® in patients with neurasthenia–A randomized, double-blind, placebo-controlled clinical trial
J Hellhammer, L Spitznagel-Schminke, C Semaca… - medRxiv, 2022 - medrxiv.org
Introduction The term neurasthenia has been introduced in the late 19th century. Stress was
indicated as one of the main triggers. Many treatment options are available to reduce the …
indicated as one of the main triggers. Many treatment options are available to reduce the …